Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: The role of microRNAs

Oncotarget

Volumn 6, Issue 7, 2015, Pages 5412-5425

  Ai, Feiyan ^a,b   Zhang, Xuemei ^a,b   Li, Xiayu ^a,b   Qin, Zailong ^c   Ye, Qiurong ^c   Tian, Li ^a,b   Tang, Anliu ^a,b   Li, Nan ^a,b   Li, Guiyuan ^b,c   Ma, Jian ^b,c   Shen, Shourong ^a,b  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b Key Laboratory of Nonresolving Inflammation and Cancer   (China)

^c Central South University   (China)

Author keywords

Colitis associated cancer; Dicer1; Matrix metalloproteinases; MicroRNAs; Non resolving inflammation

Indexed keywords

COLLAGENASE 3; DICER; DICER1; MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 128; MICRORNA 134; MICRORNA 330; STROMELYSIN; STROMELYSIN 2; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLITIS; COLITIS ASSOCIATED CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUSE MODEL; NONHUMAN; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED; COLONIC NEOPLASMS; DRUG SCREENING; ENZYME IMMUNOASSAY; ENZYMOLOGY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLITIS; COLONIC NEOPLASMS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925002846     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3027     Document Type: Article

References (41)

1. Hanahan D, Weinberg R A. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-74.
2. Li Y. Chronic inflammation and gallbladder cancer. Cancer letters. 2014; 345:242-8.
3. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer letters. 2014; 345:196-202.
4. Nguyen D P, Li J, Tewari A K. Inflammation and prostate cancer: the role of interleukin 6 (IL-6). BJU international. 2014; 113:986-92.
5. Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer letters. 2014; 345:235-41.
6. Okayasu I, Ohkusa T, Kajiura K. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 1996; 39:87-92.
7. Tang A, Li N, Li X, Yang H, Wang W, Zhang L, Li G, Xiong W, J Ma, Shen S. Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model. Carcinogenesis. 2012; 33:1375-83.
8. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation research. 2003; 92:827-39.
9. Curran S, Murray G I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000; 36:1621-30.
10. Dufour A and C M Overall. Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends in pharmacological sciences. 2013; 34:233-42.
11. Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nature reviews. immunology. 2013; 13:649-65.
12. Tili E, Michaille J J, Cimino A, Costinean S, Dumitru C D, Adair B, Fabbri M, Alder H, Liu C G. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007; 179:5082-9.
13. Liu Y, Chen Q, Song Y, Lai L, Wang J, Yu H, Cao X, Wang Q. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS letters. 2011; 585:1963-8.
14. Ranjha R, Paul J. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflammation research. 2013; 62:343-55.
15. Clapper M L, Cooper H S, Chang W C. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta pharmacologica Sinica. 2007; 28:1450-9.
16. Piperi C, Papavassiliou A G. Molecular mechanisms regulating matrix metalloproteinases. Current topics in medicinal chemistry. 2012; 12:1095-112.
17. Kumar M S, Lu J, Mercer K L, Golub T R, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature genetics. 2007; 39:673-7.
18. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grunert S. Autocrine PDGFR signaling promotes mammary cancer metastasis. The Journal of clinical investigation. 2006; 116:1561-70.
19. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annual review of immunology. 2012; 30:677-706.
20. Coussens L M, Werb Z. Inflammation and cancer. Nature. 2002; 420:860-7.
21. Wang W, Li X, Zheng D, Zhang D, Huang S, Zhang X, Ai F, Wang X, Ma J, Xiong W, Zhou Y. Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model. Inflammation research. 2013; 62:669-80.
22. Popivanova B K, Kostadinova F I, Furuichi K, Shamekh M M, Kondo T, Wada T, Egashira K, Mukaida N. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer research. 2009; 69:7884-92.
23. Shang K, Bai Y P, Wang C, Wang Z, Gu H Y, Du X, Zhou X Y, Zheng C L, Chi Y Y. Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PloS one. 2012; 7:e51848.
24. Rath T, Roderfeld M, Graf J, Wagner S, Vehr A K, Dietrich C, Geier A, Roeb E. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?. Inflammatory bowel diseases. 2006; 12:1025-35.
25. Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75:843-54.
26. Reinhart B J, Slack F J, Basson M, Pasquinelli A E, Bettinger J C, Rougvie A E, Horvitz H R, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403:901-6.
27. Sun Y, Cai J, Ma F, Lu P, Huang H, Zhou J. miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunology letters. 2012; 146:25-30.
28. Qi J, Qiao Y, Wang P, Li S, Zhao W, Gao C. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-kappaB1 in murine macrophages. FEBS letters. 2012; 586:1201-7.
29. Taganov K D, Boldin M P, Chang K J, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:12481-6.
30. Jiang P, Liu R, Zheng Y, Liu X, Chang L. MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages. Experimental cell research. 2012; 318:1175-84.
31. Lee K H, Chen Y L, Yeh S D, Hsiao M, Lin J T, Goan Y G, Lu P J. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene. 2009; 28:3360-70.
32. Li J, Wang Y, Luo J, Fu Z, Ying J. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS letters. 2012; 586:3761-5.
33. Li M, Fu W, Wo L, Shu X, Liu F, Li C. miR-128 and its target genes in tumorigenesis and metastasis. Experimental cell research. 2013; 319:3059-64.
34. Li Y, Zhu X, Xu W. miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42. Biochemical and biophysical research communications. 2013; 431:560-5.
35. Mao Y, Chen H, Lin Y, Xu X, Hu Z, Zhu Y, Wu J. microRNA-3 inhibits cell motility by downregulating Sp1 in prostate cancer cells. Oncology reports. 2013; 30:327-33.
36. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer science. 2005; 96:111-5.
37. Khoshnaw S M, Rakha E A, Abdel-Fatah T M, Nolan C C, Hodi Z, Macmillan D R, Ellis I O, Green A R. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast cancer research and treatment. 2012; 135:403-13.
38. Iliou MS, da Silva-Diz V, Carmona FJ, Ramalho-Carvalho J, Heyn H, Villanueva A, Muñoz P and Esteller M. Impaired DICER1 function promotes stemness and metastasis in colon cancer. Oncogene. 2014; 33:4003-15.
39. Tarallo V, Hirano Y, Gelfand B D, Dridi S, Kerur N, Kim Y, Cho W G, Kaneko H, Fowler B J, Bogdanovich S, Albuquerque R J, Hauswirth W W, Chiodo V A, Kugel J F, Goodrich J A, Ponicsan S L, Chaudhuri G, Murphy M P, Dunaief J L, Ambati B K, Ogura Y, Yoo J W, Lee D K, Provost P, Hinton D R, Nunez G, Baffi J Z. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell. 2012; 149:847-59.
40. Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C, Cao L, Tang K, Shen S, Li G. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. International journal of cancer. 2008; 123:2065-72.
41. Zheng L, Jiang G, Mei H, Pu J, Dong J, Hou X, Tong Q. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer. 2010; 10:33.